Chiglitazar placebo
Sponsors
Yanbing Li, Shanghai Jiao Tong University School of Medicine
Conditions
128 Patients Were Randomly Assigned 1:1Changes in HbA1C From Baseline at 18 Weeks of TreatmentEfficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM PatientsInvestigatorInitiate TrialMASH - Metabolic Dysfunction-Associated SteatohepatitisMetformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic EffectMetformin and Insulin Glargine Combined With Chiglitazar Sodium Tablets 48mg/ Day GroupMetformin and Insulin Glargine Combined With Placebo Group